Scholarlink

Purpose <p>This study aimed to estimate the prognostic value of the inflammatory indexes (NLR, PLR, LMR, SII, and SIM) in the prognosis of patients with HNSCC.</p> Methods <p>We retrospectively studied 396 patients with HNSCC diagnosed and managed over the last decade in the First Otolaryngology department of Hippokrateion hospital. The inflammatory marker counts were obtained from the pre-operative blood tests, and the survival data were recorded through the patients’ follow-up<b>.</b> The Kaplan-Meier method, the Cox proportional hazards model, and the receiver operating characteristics (ROC) curve were used to determine the prognostic values of the inflammatory markers and other factors.</p> Results <p>Factors found to be significantly associated with both DFS and OS were higher body mass index (BMI), tumor location, cancer stage (patients with advanced cancer stage reported lower DFS and OS), primary treatment, ECOGI PS scale and Charlson Index. Inflammatory marker PLR was found to be a significant predictor in both DFS (HR = 1.329; 95% CI = 1.041, 1.697) and OS (HR = 1.398; 95% CI = 1.073, 1.823), indicating that patients with higher PLR (cut off equal to 155) have a higher hazard of death. The same findings were present for SII regarding DFS (HR = 1.280; 95%CI = 1.013, 1.618), whereas the HR regarding OS was borderline but non-significant (HR = 1.168; 95%CI = 0.895, 1.525).</p> Conclusion <p>Platelet-based inflammation markers were qualified as novel and independent prognostic factors, and they could be useful biomarkers for predicting survival outcomes in patients with HNSCC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prognostic value of systemic inflammatory markers in head and neck squamous cell carcinoma

  • 期刊论文

  • 发表日期：

    2025年10月24日

查看全文
  • Zoi Zachou,
  • Konstantinos Katsas,
  • Dimitrios Dimitroulis,
  • Ioannis Seggas,
  • Efthymios Kyrodimos

摘要

Purpose

This study aimed to estimate the prognostic value of the inflammatory indexes (NLR, PLR, LMR, SII, and SIM) in the prognosis of patients with HNSCC.

Methods

We retrospectively studied 396 patients with HNSCC diagnosed and managed over the last decade in the First Otolaryngology department of Hippokrateion hospital. The inflammatory marker counts were obtained from the pre-operative blood tests, and the survival data were recorded through the patients’ follow-up. The Kaplan-Meier method, the Cox proportional hazards model, and the receiver operating characteristics (ROC) curve were used to determine the prognostic values of the inflammatory markers and other factors.

Results

Factors found to be significantly associated with both DFS and OS were higher body mass index (BMI), tumor location, cancer stage (patients with advanced cancer stage reported lower DFS and OS), primary treatment, ECOGI PS scale and Charlson Index. Inflammatory marker PLR was found to be a significant predictor in both DFS (HR = 1.329; 95% CI = 1.041, 1.697) and OS (HR = 1.398; 95% CI = 1.073, 1.823), indicating that patients with higher PLR (cut off equal to 155) have a higher hazard of death. The same findings were present for SII regarding DFS (HR = 1.280; 95%CI = 1.013, 1.618), whereas the HR regarding OS was borderline but non-significant (HR = 1.168; 95%CI = 0.895, 1.525).

Conclusion

Platelet-based inflammation markers were qualified as novel and independent prognostic factors, and they could be useful biomarkers for predicting survival outcomes in patients with HNSCC.